362 related articles for article (PubMed ID: 15184501)
41. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
42. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
Khattri R; Cox T; Yasayko SA; Ramsdell F
Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581
[TBL] [Abstract][Full Text] [Related]
43. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
45. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice.
Hawiger D; Tran E; Du W; Booth CJ; Wen L; Dong C; Flavell RA
J Immunol; 2008 Mar; 180(5):3140-7. PubMed ID: 18292537
[TBL] [Abstract][Full Text] [Related]
46. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system.
Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C
Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729
[TBL] [Abstract][Full Text] [Related]
47. [Influence of anti-ICOS antibody on quantity and function of CD4(+);CD25(+);Foxp3(+);Treg from lymph and blood of rats with bronchial asthma].
Zhao L; Feng XB; Wang YS; Cui QQ; Cao YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1029-32. PubMed ID: 23046932
[TBL] [Abstract][Full Text] [Related]
48. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
49. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
[TBL] [Abstract][Full Text] [Related]
50. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production.
Yu L; Yang F; Zhang F; Guo D; Li L; Wang X; Liang T; Wang J; Cai Z; Jin H
Cell Death Dis; 2018 Sep; 9(9):905. PubMed ID: 30185773
[TBL] [Abstract][Full Text] [Related]
51. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
52. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes.
Łuczyński W; Wawrusiewicz-Kurylonek N; Stasiak-Barmuta A; Urban R; Iłendo E; Urban M; Hryszko M; Kretowski A; Górska M
Acta Biochim Pol; 2009; 56(2):361-70. PubMed ID: 19547759
[TBL] [Abstract][Full Text] [Related]
53. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
Lindley S; Dayan CM; Bishop A; Roep BO; Peakman M; Tree TI
Diabetes; 2005 Jan; 54(1):92-9. PubMed ID: 15616015
[TBL] [Abstract][Full Text] [Related]
54. Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.
Martin-Orozco N; Li Y; Wang Y; Liu S; Hwu P; Liu YJ; Dong C; Radvanyi L
Cancer Res; 2010 Dec; 70(23):9581-90. PubMed ID: 21098714
[TBL] [Abstract][Full Text] [Related]
55. An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice.
Zhu X; Wang M; Crump CH; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G550-8. PubMed ID: 19571233
[TBL] [Abstract][Full Text] [Related]
56. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
Gotsman I; Grabie N; Gupta R; Dacosta R; MacConmara M; Lederer J; Sukhova G; Witztum JL; Sharpe AH; Lichtman AH
Circulation; 2006 Nov; 114(19):2047-55. PubMed ID: 17060381
[TBL] [Abstract][Full Text] [Related]
57. PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells.
Mazerolles F; Rieux-Laucat F
PLoS One; 2021; 16(11):e0260206. PubMed ID: 34793567
[TBL] [Abstract][Full Text] [Related]
58. Quantification of regulatory T cells in patients with systemic lupus erythematosus.
Crispin JC; Martínez A; Alcocer-Varela J
J Autoimmun; 2003 Nov; 21(3):273-6. PubMed ID: 14599852
[TBL] [Abstract][Full Text] [Related]
59. Are non-traditional CD4(+) CD69(+) CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?
Xu D; Wang FS
J Gastroenterol Hepatol; 2011 Oct; 26(10):1469-70. PubMed ID: 21950742
[No Abstract] [Full Text] [Related]
60. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
